BackRTW Biotech Opportunities Ltd USD Overview
RTW Biotech Opportunities Ltd USD

RTW Biotech Opportunities Ltd USD Return on Equity

Valuation check: RTW.L's ROE is 39.34%, above the sector sector average of 10.27%.

Get informed when a big investor buys or sells

+ Follow

ROE

39.34%

Return on Equity

39.34%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

RTW Biotech Opportunities Ltd USD (RTW.L) FAQ

The latest ROE for RTW.L is 39.34%. That is above the sector sector average of 10.27%. Investors often review this figure alongside RTW Biotech Opportunities Ltd USD's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, RTW.L currently prints 39.34% for ROE, while the sector average sits near 10.27%. That is roughly 283.3% above the sector mean. Large gaps often invite a closer look at RTW Biotech Opportunities Ltd USD's growth, margins, and balance sheet.

Return on Equity shows how effectively RTW Biotech Opportunities Ltd USD converts resources into returns. At 39.34%, RTW.L may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RTW.L's ROE (39.34%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers